Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 03 December 2025

Sec. Neuropharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1750932

Correction: The role of panax notoginseng saponins in cerebrovascular neurological disorders: an overview of mechanisms and functions

This article is a correction to:

  1. The role of Panax notoginseng saponins in cerebrovascular neurological disorders: an overview of mechanisms and functions

    1. Read original article
Bin WangBin Wang1Xu GaoXu Gao2Yali ZhangYali Zhang2Yuhua XiaoYuhua Xiao2Tong ChenTong Chen1Zhouying ShiZhouying Shi1Yue YuanYue Yuan3Ping Li Ping Li3*
  • 1College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China
  • 2College of Basic Medicine, Changchun University of Chinese Medicine, Changchun, China
  • 3College of Nursing, Changchun University of Chinese Medicine, Changchun, China

A Correction on
The role of panax notoginseng saponins in cerebrovascular neurological disorders: an overview of mechanisms and functions

by Wang B, Gao X, Zhang Y, Xiao Y, Chen T, Shi Z, Yuan Y and Li P (2025). Front. Pharmacol. 16:1693253. doi: 10.3389/fphar.2025.1693253

An incorrect Funding statement was provided.

The funder “the National Traditional Chinese Medicine Clinical Excellence Talent Advanced Study Program (National Administration of TCM Personnel and Education Letter [2022] No. 239)” was erroneously omitted.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: panax notoginseng saponins, cerebrovascular, neurological diseases, pharmacologic effects, mechanism of action

Citation: Wang B, Gao X, Zhang Y, Xiao Y, Chen T, Shi Z, Yuan Y and Li P (2025) Correction: The role of panax notoginseng saponins in cerebrovascular neurological disorders: an overview of mechanisms and functions. Front. Pharmacol. 16:1750932. doi: 10.3389/fphar.2025.1750932

Received: 20 November 2025; Accepted: 21 November 2025;
Published: 03 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Wang, Gao, Zhang, Xiao, Chen, Shi, Yuan and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ping Li, bGlwaW5nQGNjdWNtLmVkdS5jbg==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.